solutions

Chapter 38 - The Unseen Infection

Two weeks after Julian’s return from Chicago, an unexpected crisis struck not the corporate or syndicate worlds, but the very core of St. Catherine’s clinical operations.

At 7:00 a.m. on a cold Thursday, Emma was reviewing the daily laboratory culture reports in her administrative office when Dr. Chen burst through the door without knocking.

His face was pale beneath his surgical mask, his brow furrowed with extreme alarm.

“Emma, we have an outbreak in the post-operative recovery ward,” Dr. Chen said, dropping five clinical printouts onto her desk. “Four surgical patients developed sudden, high-grade fevers, hemodynamic instability, and septic shock within six hours of leaving Operating Rooms 2 and 3.”

Emma was on her feet instantly. “What organism?”

“That’s the terrifying part,” Chen replied, his hands shaking slightly. “It’s Acinetobacter baumannii, pan-drug resistant. None of our first-line or second-line carbapenem antibiotics are touching it. The minimum inhibitory concentrations are off the charts. If this spreads to the neonatal unit or the pediatric wing, we’re looking at a catastrophe.”

Emma didn’t hesitate. She grabbed her stethoscope, snapped her badge into place, and tied her blond hair into a tight, practical knot.

“Activate Protocol Zero immediately,” Emma commanded, walking rapidly into the corridor with Chen beside her. “Isolate the third floor. Seal the positive-pressure ventilation in Operating Rooms 2 and 3. I want every surface, every anesthesia cart, and every central line tray cultured within forty-five minutes. Inform the state epidemiologist, but do not release a public alert until we trace the vector. We cannot have families panicking and pulling septic patients out of the ICU.”

Emma spent the next seven hours inside the isolation ward, wearing full personal protective equipment—double gloves, N95 respirator, fluid-resistant gown, and face shield. She personally managed the central venous access lines, administered experimental polymyxin infusions, and monitored urine outputs and arterial blood gases.

Her eyes burned behind the plastic shield, her back screamed with tension, but her clinical leadership was flawless. Under her direction, three of the four patients began responding to high-dose continuous colistin therapy, their arterial blood pressures stabilizing by late afternoon.

By 5:00 p.m., the head microbiologist ran into the observation ante-room holding a sterile swab tube.

“Director Hayes! We found the vector!”

Emma stripped off her outer gloves and took the report through the glass partition. “Where?”

“It wasn't the surgical instruments or the air handling units,” the microbiologist said, catching his breath. “It was a new batch of pre-filled heparin flush syringes delivered yesterday morning by an emergency contracted distributor named Vanguard Bio-Supply. The internal fluid in the syringes was contaminated during packaging at an overseas plant.”

Emma’s eyes narrowed into sharp, dangerous slits. Vanguard Bio-Supply.

She pulled up the state hospital vendor registry on her tablet. Vanguard Bio-Supply had been awarded an emergency contingency contract three weeks ago by the regional hospital purchasing consortium—a decision made by state procurement officers while Emma had been dealing with Chloe’s recovery.

And the principal shareholder listed on Vanguard’s secondary corporate filings was a familiar holding company based in Wilmington, Delaware: Aegis Capital Partners.

Meredith Vance’s old network. Even from behind federal bars, the remnants of that corporate cabal had cut corners, dumping cheap, unsterilized medical supplies into public hospitals to recoup their legal defense costs.

Emma tore off her protective gown, threw it into the biohazard bin, and walked straight to her office phone.

She dialed Julian’s direct line.

“Julian,” Emma said, her voice shaking with an outrage so deep it bordered on lethal. “They didn't come with guns this time. They came with contaminated syringes. We have four patients fighting for their lives in our ICU because Aegis dumped infected medical supplies into our supply chain.”

Julian’s response was immediate, terrifying in its absolute stillness.

“Where are the distribution warehouses, Emma?”

May you like

“Port Elizabeth, New Jersey,” Emma said. “There are forty thousand contaminated syringes scheduled for delivery to seventeen regional trauma centers tomorrow morning. If those boxes leave the docks, hundreds of people will die of septic shock.”

“They won't leave the docks,” Julian said. “Stay with your patients, Emma. I’ll handle the quarantine.”

Related Stories

Other posts